STARTRK-2
Hoffmann-La Roche
Hoffmann-La Roche
Endeavor Biomedicines, Inc.
ViroMissile, Inc.
AstraZeneca
MacroGenics
Immatics US, Inc.
Transgene
HiFiBiO Therapeutics
Bayer
GlaxoSmithKline
HiFiBiO Therapeutics
Actym Therapeutics, Inc.
Travera Inc
Valo Therapeutics Oy
Guangzhou FineImmune Biotechnology Co., LTD.
Numab Therapeutics AG
Iovance Biotherapeutics, Inc.
Eli Lilly and Company
Eli Lilly and Company
Labcorp Corporation of America Holdings, Inc
BostonGene
Agenus Inc.
GI Innovation, Inc.
Y-mAbs Therapeutics
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Xencor, Inc.
Gene Surgery LLC
Cardinal Health 414, LLC
Innolake Biopharm
Presage Biosciences
Pfizer
DNAtrix, Inc.
BioEclipse Therapeutics
Adaptimmune
Deciphera Pharmaceuticals, LLC
Sumitomo Pharma America, Inc.
OncoResponse, Inc.
Hoffmann-La Roche
Kineta Inc.
Pfizer
Bristol-Myers Squibb
Prelude Therapeutics
Nektar Therapeutics
Cancer Intelligence Care Systems, Inc.
Quadriga Biosciences, Inc.
Presage Biosciences
MacroGenics
Pfizer
Oncovir, Inc.
SpeciCare